Fatty liver disease exacerbates atherosclerosis, but the mechanisms are incompletely understood. A new collaborative study led by ISD investigators identifies D-dopachrome tautomerase (D-DT/MIF-2) as an atypical chemokine that promotes both atherosclerosis and hepatic lipid accumulation. The researchers also define the underlying receptor mechanism